Measures of physiological function · people with varicose veins without venous ulceration
1 finding from 1 review
Complications (1 week, 4 weeks and up to 6 weeks' postpartumc) · people with varicose veins without venous ulceration
1 finding from 1 review
Compliance · people with varicose veins without venous ulceration
1 finding from 1 review
Comfort, tolerance and acceptability of wearing stockings (1 week and up to 6 weeks' postpartumc) · people with varicose veins without venous ulceration
1 finding from 1 review
Quality of life (3 months) · people with varicose veins without venous ulceration
1 finding from 1 review
Absolute claudication distance (MWD + PWT) (in meters) · intermittent claudication
1 finding from 1 review
Initial claudication distance (PFWD + COT) (in meters) · intermittent claudication
1 finding from 1 review
Quality of life · intermittent claudication
1 finding from 1 review
Progression of disease (to Fontaine stage III or IV, or necessity for intervention (endovascular or surgery)) · intermittent claudication
1 finding from 1 review
Side effects of propionyl‐L‐carnitine regimen · intermittent claudication
1 finding from 1 review
Ankle brachial index · intermittent claudication
1 finding from 1 review
Resolution or improvement of telangiectasias ( · people with telangiectasias and reticular veins
1 finding from 1 review
Adverse events ‐ hyperpigmentation ( · people with telangiectasias and reticular veins
Sclerotherapy probably leads to higher adverse events ‐ hyperpigmentation ( compared with placebo (moderate certainty).
1 finding from 1 review
Adverse events ‐ matting ( · people with telangiectasias and reticular veins
Sclerotherapy probably leads to higher adverse events ‐ matting ( compared with placebo (moderate certainty).
1 finding from 1 review
Pain ( · people with telangiectasias and reticular veins
1 finding from 1 review
Recurrence · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to resolution · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life · people with telangiectasias and reticular veins
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality · atherosclerotic cardiovascular disease
EDTA showed no clear difference in all‐cause mortality compared with placebo (low certainty).
1 finding from 1 review
Coronary heart disease mortality – CHD deaths · atherosclerotic cardiovascular disease
It is very uncertain whether EDTA changes coronary heart disease death compared with placebo (very low certainty).
1 finding from 1 review